January 10, 2019
Rose
“If we don’t do this as an industry, I think there will be other alternatives that will be more onerous for us,” Johnson & Johnson CEO Alex Gorsky said at the J.P. Morgan Healthcare Conference in California. Drug pricing was just one of the many topics that were being hotly discussed at the annual event that draws the movers-and-shakers in the industry.
from Kaiser Health News http://bit.ly/2M58tzq
January 10, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Patients Are Confessing Suicidal Thoughts To Apps Meant To Manage Health Problems Like Diabetes, Leaving Startups To Grapple With What To Do- Personal, Banking Data From Millions Of Survivors Of U.S. Environmental Disasters Accidentally Shared By FEMA
- CMS Issues Guidance To Help Determine If Assisted-Living Facilities Are Meeting Medicaid Funding Requirements
- First Edition: March 25, 2019
- After Reports Of Breast Implants’ Link To Rare Cancer, FDA To Hold Hearing On Potential Negative Health Effects
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment